We are live on ! Find out more
TI

tru Independence Portfolio holdings

AUM $202M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
+8.29%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
–
AUM
$695M
AUM Growth
–
Cap. Flow
+$902M
Cap. Flow %
129.79%
Top 10 Hldgs %
22.88%
Holding
959
New
957
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$61.9M
2
NDSN icon
Nordson
NDSN
+$40.3M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$36.7M
4
DTE icon
DTE Energy
DTE
+$18.1M
5
GM icon
General Motors
GM
+$14.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 16.84%
2 Technology 10.24%
3 Industrials 8.78%
4 Financials 8.55%
5 Consumer Discretionary 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZTO icon
776
ZTO Express
ZTO
$18.2B
$3K ﹤0.01%
+100
New +$2.16K
SWAV
777
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$3K ﹤0.01%
+100
New +$3.69K
TYME
778
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$3K ﹤0.01%
+2,500
New +$3.03K
WORK
779
DELISTED
Slack Technologies, Inc.
WORK
$3K ﹤0.01%
+100
New +$2.23K
LK
780
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
$3K ﹤0.01%
+100
New +$2.53K
CFRX
781
DELISTED
ContraFect Corporation
CFRX
$3K ﹤0.01%
+1
New +$290
ACB
782
Aurora Cannabis
ACB
$165M
$2K ﹤0.01%
+21
New +$7.83K
AMRN
783
Amarin Corp
AMRN
$284M
$2K ﹤0.01%
+30
New +$11.4K
ARAY icon
784
Accuray
ARAY
$28.4M
$2K ﹤0.01%
+1,000
New +$2.77K
BURL icon
785
Burlington
BURL
$22B
$2K ﹤0.01%
+10
New +$2.09K
CBRE icon
786
CBRE Group
CBRE
$40.8B
$2K ﹤0.01%
+48
New +$2.66K
CGNX icon
787
Cognex
CGNX
$10.3B
$2K ﹤0.01%
+46
New +$2.38K
CRI icon
788
Carter's
CRI
$1.43B
$2K ﹤0.01%
+17
New +$1.72K
CRON
789
Cronos Group
CRON
$1.05B
$2K ﹤0.01%
+275
New +$2.1K
CVCO icon
790
Cavco Industries
CVCO
$4.39B
$2K ﹤0.01%
+11
New +$2.16K
DEA
791
Easterly Government Properties
DEA
$1.18B
$2K ﹤0.01%
+32
New +$1.81K
ENTG icon
792
Entegris
ENTG
$19.7B
$2K ﹤0.01%
+35
New +$1.69K
EPAM icon
793
EPAM Systems
EPAM
$4.69B
$2K ﹤0.01%
+8
New +$1.57K
FSLY icon
794
Fastly Inc
FSLY
$3.17B
$2K ﹤0.01%
+100
New +$2.11K
GHYG icon
795
iShares US & Intl High Yield Corp Bond ETF
GHYG
$184M
$2K ﹤0.01%
+44
New +$2.16K
GNK icon
796
Genco Shipping & Trading
GNK
$1.17B
$2K ﹤0.01%
+300
New +$3.09K
HSBC icon
797
HSBC
HSBC
$355B
$2K ﹤0.01%
+80
New +$3.03K
HUM icon
798
Humana
HUM
$46.7B
$2K ﹤0.01%
+5
New +$1.59K
ICUI icon
799
ICU Medical
ICUI
$3.93B
$2K ﹤0.01%
+9
New +$1.55K
IONS icon
800
Ionis Pharmaceuticals
IONS
$9.35B
$2K ﹤0.01%
+36
New +$2.15K
30 31
32
33 34

Similar funds

4FG
4Thought Financial Group Syosset, New York $202M AUM 11.53% 1-Year Est. Return
BFA
Brendel Financial Advisors Hanover, New Hampshire $202M AUM 37.99% 1-Year Est. Return
PCMK
Paragon Capital Management (Kansas) Overland Park, Kansas $202M AUM 26.44% 1-Year Est. Return
CWM
CarsonAllaria Wealth Management Glen Carbon, Illinois $202M AUM 15.75% 1-Year Est. Return
AFWM
Arta Finance Wealth Management Mountain View, California $202M AUM
HWMO
Heritage Wealth Management (Ohio) Cincinnati, Ohio $202M AUM 23.85% 1-Year Est. Return
PCM
Pointe Capital Management Grosse Pointe Farms, Michigan $202M AUM 17.2% 1-Year Est. Return
BSA
Bull Street Advisors Savannah, Georgia $202M AUM 11.06% 1-Year Est. Return

tru Independence's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for tru Independence, which disclosed 959 positions worth $695M. Its ten largest holdings account for 23% of the portfolio.

Its largest position is Bristol-Myers Squibb: 1,081,698 shares worth $49.3M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, followed by Technology and Industrials.

  • tru Independence's largest Q4 2019 buy was Bristol-Myers Squibb: 1,081,698 shares worth $49.3M.
  • tru Independence's ten largest holdings make up 23% of its $695M portfolio in Q4 2019.
  • tru Independence disclosed 959 positions in Q4 2019, its first 13F filing on record.

Based on tru Independence's 13F filing for Q4 2019, filed 19 May 2020.